Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This is a randomized, double-blind, placebo-controlled study of B07, administered daily by subcutaneous (SC) injection, in up to 120 patients with newly diagnosed metastatic colorectal cancer. This study will evaluate different doses of B07 on weight, body composition and BMI in patients with sub-optimal BMIs (≤ 29 kg/m\^2). Treatment will start at the second cycle of first-line cancer chemotherapy and continue for 12-weeks with the goal of maintaining body weight and muscle mass in patients und
Sponsor: Endevica Bio
Check if you qualify for this colorectal cancer clinical trial in Tucson, AZ
If you're searching for colorectal cancer treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.